Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1952 1
1956 2
1957 1
1958 5
1960 3
1962 2
1965 5
1966 15
1967 16
1968 31
1969 37
1970 39
1971 55
1972 47
1973 69
1974 88
1975 63
1976 84
1977 87
1978 61
1979 99
1980 96
1981 173
1982 148
1983 156
1984 136
1985 157
1986 145
1987 140
1988 121
1989 136
1990 137
1991 145
1992 165
1993 224
1994 203
1995 274
1996 302
1997 314
1998 324
1999 349
2000 397
2001 377
2002 400
2003 460
2004 511
2005 451
2006 458
2007 479
2008 518
2009 577
2010 743
2011 887
2012 973
2013 1052
2014 1103
2015 1123
2016 1128
2017 1082
2018 1109
2019 593
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

17,675 results
Results by year
Filters applied: . Clear all
Page 1
Sepsis 2018: Definitions and Guideline Changes.
Napolitano LM. Surg Infect (Larchmt) 2018. PMID 29447109
BACKGROUND: Sepsis is a global healthcare issue and continues to be the leading cause of death from infection. Early recognition and diagnosis of sepsis is required to prevent the transition into septic shock, which is associated with a mortality rate of 40% or more. DISCUSSION: New definitions for sepsis and septic shock (Third International Consensus Definitions for Sepsis and Septic Shock [Sepsis-3]) have been developed. ...
BACKGROUND: Sepsis is a global healthcare issue and continues to be the leading cause of death from infection. Early recognition and …
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.
Rhodes A, et al. Crit Care Med 2017. PMID 28098591
OBJECTIVE: To provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012." DESIGN: A consensus committee of 55 international experts representing 25 international organizations was convened. ...RESULTS: The Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. ...
OBJECTIVE: To provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012." DES …
Similar but not the same: Differential diagnosis of HLH and sepsis.
Machowicz R, et al. Crit Rev Oncol Hematol 2017 - Review. PMID 28477737
Differential diagnosis of hemophagocytic lymphohistiocytosis (HLH; hemophagocytic syndrome) and sepsis is critically important because the life-saving aggressive immunosuppressive treatment, required in the effective HLH therapy, is absent in sepsis guidelines. ...The diagnosis of HLH is supported by hyperferritinemia, splenomegaly, marked cytopenias, hypofibrinogenemia, low CRP, characteristic cytokine profile and, only in adults, hypertriglyceridemia. ...
Differential diagnosis of hemophagocytic lymphohistiocytosis (HLH; hemophagocytic syndrome) and sepsis is critically important …
The recognition and management of sepsis and septic shock: a guide for non-intensivists.
Keeley A, et al. Postgrad Med J 2017 - Review. PMID 28756405
Sepsis is common, often fatal and requires rapid interventions to improve outcomes. While the optimal management of sepsis in the intensive care setting is the focus of extensive research interest, the mainstay of the recognition and initial management of sepsis will occur outside the intensive care setting. ...This review discusses the latest updates in sepsis care including the new consensus definition of sepsis, the outcome of the proCESS, ProMISe and ARISE trials of early goal directed therapy (EGDT), and the most recent guidelines from the Surviving Sepsis Campaign....
Sepsis is common, often fatal and requires rapid interventions to improve outcomes. While the optimal management of sepsis in
Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment.
Sandquist M and Wong HR. Expert Rev Clin Immunol 2014 - Review. PMID 25142036 Free PMC article.
Biomarkers have great potential to improve the diagnosis and treatment of sepsis. The available literature supports the potential utility of sTREM-1, IL-27, suPAR, neutrophil CD64, presepsin, cfDNA and miRNAs as novel diagnostic, prognostic and treatment response biomarkers. The future of sepsis biomarkers lies in extensive validation studies of such novel biomarkers across heterogeneous populations and exploration of their power in combination. ...
Biomarkers have great potential to improve the diagnosis and treatment of sepsis. The available literature supports the potent …
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.
Levy MM, et al. Crit Care Med 2003 - Review. PMID 12682500
DESIGN: Several North American and European intensive care societies agreed to revisit the definitions for sepsis and related conditions. ...The present article serves as the final report of the 2001 International Sepsis Definitions Conference. CONCLUSION: This document reflects a process whereby a group of experts and opinion leaders revisited the 1992 sepsis guidelines and found that apart from expanding the list of signs and symptoms of sepsis to reflect clinical bedside experience, no evidence exists to support a change to the definitions. ...
DESIGN: Several North American and European intensive care societies agreed to revisit the definitions for sepsis and related conditi …
Biomarkers in Sepsis.
van Engelen TSR, et al. Crit Care Clin 2018 - Review. PMID 29149935
Biomarkers can be the key to personalized targeted treatment in the future clinical management of sepsis....
Biomarkers can be the key to personalized targeted treatment in the future clinical management of sepsis....
Point of care technologies for sepsis diagnosis and treatment.
Oeschger T, et al. Lab Chip 2019 - Review. PMID 30724931 Free PMC article.
Current clinical diagnosis relies on broad physiological parameters and time consuming lab-based cell culture. If proper treatment is not provided, cases of sepsis can drastically increase in severity over the course of a few hours. ...In this review we examine developing and commercially available technologies to assess the feasibility of rapid, accurate sepsis diagnosis, with emphasis on point of care....
Current clinical diagnosis relies on broad physiological parameters and time consuming lab-based cell culture. If proper treatment is …
CE: Managing Sepsis and Septic Shock: Current Guidelines and Definitions.
Makic MBF and Bridges E. Am J Nurs 2018. PMID 29329118
In 2002, the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) launched the Surviving Sepsis Campaign (SSC) to reduce overall patient morbidity and mortality from sepsis and septic shock by driving practice initiatives based on current best evidence. ...In 2016, this task force published the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). The new definitions and recommendations included tools, based on an updated understanding of the pathobiology of sepsis, that can be used to predict adverse outcomes in patients with infection.This article discusses the new SSC treatment guidelines, changes in the sepsis bundle interventions, and the Sepsis-3 definitions and tools, all of which enable nurses to improve patient outcomes through timely collaborative action....
In 2002, the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM) launched the Surviving …
[Advances of microfluidic technologies applied in diagnosis and treatment of sepsis].
Yang R, et al. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2019 - Review. PMID 31315744 Chinese.
Early diagnosis and timely treatment can improve patient survival and long-term prognosis. Biomarkers such as procalcitonin (PCT), C-reactive protein (CRP), and interleukin-6 (IL-6) have been widely used in the early diagnosis of sepsis, but there still exist limitations on their specificity and sensitivity. ...To demonstrate the value of microfluidic technology for early diagnosis of sepsis and to guide the improvement of future research, the application of microfluidic technology in the diagnosis and treatment of sepsis was reviewed in this article....
Early diagnosis and timely treatment can improve patient survival and long-term prognosis. Biomarkers such as procalcitonin (PCT), C- …
17,675 results
Jump to page
Feedback